Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sanjay K. Lal"'
Autor:
Anchal Dass, Gandhamanagenahalli A. Rajanna, Subhash Babu, Sanjay K. Lal, Anil K. Choudhary, Raj Singh, Sanjay Singh Rathore, Ramanjit Kaur, Shiva Dhar, Teekam Singh, Rishi Raj, Kapila Shekhawat, Chandu Singh, Bipin Kumar
Publikováno v:
Sustainability; Volume 14; Issue 10; Pages: 5825
Inadequate nutrient management is one of the major challenges for sustainable soybean production in semi-arid climatic conditions. Hence, a 3-year (2015–2017) field experiment was conducted to assess the effect of foliar application of macro- and m
Autor:
Susan Ewart, John W. Holloway, Sanjay K. Lal, Hasan Arshad, Wilfried Karmaus, Gabrielle A. Lockett, Hongmei Zhang, Nelís Soto-Ramírez
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:AB74
FEBRUARY 2015 AB74 Abstracts S A T U R D A Y 237 DNA Methylation Modifies the Effect of Genotype on Atopy Risk Gabrielle A. Lockett, PhD, Nel is Soto-Ram irez, PhD, Sanjay K. Lal, Susan L. Ewart, DVM, PhD, Hasan Arshad, DM, FRCP, Hongmei Zhang, PhD,
Autor:
Nisha S. Wadhwani, Deepali P. Sundrani, Girija N. Wagh, Savita S. Mehendale, Manish M. Tipnis, Priscilla C. Joshi, Arun S. Kinare, Sanjay K. Lalwani, Narayanan S. Mani, Nomita Chandhiok, Giriraj R. Chandak, Sanjay A. Gupte, Caroline H. D. Fall, Sadhana R. Joshi
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background Preeclampsia is a major cause of maternal, fetal and neonatal morbidity and mortality, particularly in developing countries. Considering the burden of preeclampsia and its associated complications, it is important to understand th
Externí odkaz:
https://doaj.org/article/b08f9b16c2dc4cdc85b02ba465438fed
Autor:
Sharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, Sanjay K. Lalwani, Arun Narayan, Vinay Muninarayanaswam, Nithya Gogtay, Kristin Dotter, Viviane Gresset-Bourgeois
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 973-977 (2019)
A quadrivalent split-virion inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent, Sanofi Pasteur) has been available in the US since 2013 for individuals aged ≥ 6 months. Here, we describe the results of an open-label, multicenter trial (WHO
Externí odkaz:
https://doaj.org/article/56996f89851f45738c47ed28960a797c
Autor:
Sanjay K. Lalwani, Sharad Agarkhedkar, Balasubramanian Sundaram, Niranjana S. Mahantashetti, Nandini Malshe, Shalaka Agarkhedkar, Olivier Van Der Meeren, Shailesh Mehta, Naveen Karkada, Htay Htay Han, Narcisa Mesaros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 1, Pp 120-127 (2017)
Multivalent combination vaccines have reduced the number of injections and therefore improved vaccine acceptance, timeliness of administration and global coverage. The hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovir
Externí odkaz:
https://doaj.org/article/74df3590d8e14f68b1dcac7fc7378524